Literature DB >> 12057897

Molecular rearrangements and morphology in thyroid cancer.

Todd G Kroll1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12057897      PMCID： PMC1850815          DOI： 10.1016/S0002-9440(10)61142-X

Source DB:  PubMed          Journal:  Am J Pathol        ISSN： 0002-9440            Impact factor:   4.307


× No keyword cloud information.
  50 in total

Review 1.  Follicular-patterned lesions of the thyroid: the bane of the pathologist.

Authors:  Zubair W Baloch; Virginia A Livolsi
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

2.  Why there is the tendency to "overdiagnose" the follicular variant of papillary thyroid carcinoma.

Authors:  Andrew A Renshaw; Edwin W Gould
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

Review 3.  The role of PML in tumor suppression.

Authors:  Paolo Salomoni; Pier Paolo Pandolfi
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

4.  PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

Authors:  M Grieco; M Santoro; M T Berlingieri; R M Melillo; R Donghi; I Bongarzone; M A Pierotti; G Della Porta; A Fusco; G Vecchio
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Microdissection is essential for gene expression profiling of clinically resected cancer tissues.

Authors:  Yuko Sugiyama; Kazuo Sugiyama; Yasuo Hirai; Futoshi Akiyama; Katsuhiko Hasumi
Journal:  Am J Clin Pathol       Date:  2002-01       Impact factor: 2.493

6.  The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Authors:  Gennaro Chiappetta; Paolo Toti; Francesco Cetta; Ada Giuliano; Francesca Pentimalli; Ida Amendola; Stefano Lazzi; Mario Monaco; Luca Mazzuchelli; Piero Tosi; Massimo Santoro; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

7.  Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma: a search for the early precursors of papillary cancer.

Authors:  Alfredo Fusco; Gennaro Chiappetta; Pei Hui; Ginesa Garcia-Rostan; Lauren Golden; Barbara K Kinder; Deborah A Dillon; Ada Giuliano; Anna Maria Cirafici; Massimo Santoro; Juan Rosai; Giovanni Tallini
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

Review 8.  Perspectives on the development of a molecularly targeted agent.

Authors:  Brian J Druker
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

9.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia.

Authors:  Masakazu Higuchi; Darin O'Brien; Parasakthy Kumaravelu; Noel Lenny; Eng-Juh Yeoh; James R Downing
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743

10.  Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia.

Authors:  Adolfo A Ferrando; Donna S Neuberg; Jane Staunton; Mignon L Loh; Christine Huard; Susana C Raimondi; Fred G Behm; Ching Hon Pui; James R Downing; D Gary Gilliland; Eric S Lander; Todd R Golub; A Thomas Look
Journal:  Cancer Cell       Date:  2002-02       Impact factor: 31.743
View more
  7 in total

Review 1.  Tumors of thyroid follicular epithelium: where have we been and where are we going?.

Authors:  Arthur S Tischler; Ronald A DeLellis
Journal:  Endocr Pathol       Date:  2002       Impact factor: 3.943

Review 2.  When thyroid carcinoma goes bad: a morphological and molecular analysis.

Authors:  Sylvia Papp; Sylvia L Asa
Journal:  Head Neck Pathol       Date:  2015-03-25

3.  PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt.

Authors:  Jee-Yin Ahn; Yuanxin Hu; Todd G Kroll; Paulette Allard; Keqiang Ye
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-26       Impact factor: 11.205

4.  Genetic and biological subgroups of low-stage follicular thyroid cancer.

Authors:  Christopher A French; Erik K Alexander; Edmund S Cibas; Vania Nose; Julia Laguette; William Faquin; Jeff Garber; Francis Moore; Jonathan A Fletcher; P Reed Larsen; Todd G Kroll
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

5.  Family of microRNA-146 Regulates RARβ in Papillary Thyroid Carcinoma.

Authors:  Agnieszka Anna Czajka; Anna Wójcicka; Anna Kubiak; Marta Kotlarek; Elwira Bakuła-Zalewska; Łukasz Koperski; Wiesław Wiechno; Krystian Jażdżewski
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

6.  Gene expression profiling of normal thyroid tissue from patients with thyroid carcinoma.

Authors:  Roberto Ria; Vittorio Simeon; Assunta Melaccio; Giovanna Di Meo; Stefania Trino; Carmela Mazzoccoli; Ilaria Saltarella; Aurelia Lamanuzzi; Annalisa Morano; Angela Gurrado; Alessandro Pasculli; Gaetano Lastilla; Pellegrino Musto; Antonia Reale; Franco Dammacco; Angelo Vacca; Mario Testini
Journal:  Oncotarget       Date:  2016-05-17

7.  MiR-509-5p improves the proliferative and invasive abilities of papillary thyroid carcinoma cells by inhibiting SFRP1.

Authors:  Chunxiao Yang; Yingluan Wang; Wenyi Yang; Yujun Gao; Bo Zhao; Xingwang Yang
Journal:  Arch Med Sci       Date:  2019-06-10       Impact factor: 3.318
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.